UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039333
Receipt number R000044855
Scientific Title Consideration of the validity of Thoracoabdominal nerves through perichondral approach Block to laparoscopic cholecystectomy and laparoscopic colectomy
Date of disclosure of the study information 2020/02/04
Last modified on 2020/12/17 12:43:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Consideration of the validity of Thoracoabdominal nerves through perichondral approach Block to laparoscopic cholecystectomy and laparoscopic colectomy

Acronym

Consideration of the validity of Thoracoabdominal nerves through perichondral approach Block to laparoscopic cholecystectomy and laparoscopic colectomy

Scientific Title

Consideration of the validity of Thoracoabdominal nerves through perichondral approach Block to laparoscopic cholecystectomy and laparoscopic colectomy

Scientific Title:Acronym

Consideration of the validity of Thoracoabdominal nerves through perichondral approach Block to laparoscopic cholecystectomy and laparoscopic colectomy

Region

Japan


Condition

Condition

laparoscopic cholecystectomy
laparoscopic colectomy

Classification by specialty

Gastrointestinal surgery Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Up to now, epidural anesthesia has been performed as perioperative analgesia for trunk surgery, but peripheral nerve blocks have been increasing in recent years. This is due to an increase in contraindications for epidural anesthesia due to anticoagulant therapy and advances in ultrasound diagnostic equipment.
TAP blocks have been used for abdominal analgesia, but TAP blocks required two punctures for upper or lower abdominal surgery.
The TAPA block reported in 2019 is said to be possible with two punctures for cases requiring upper and lower abdominal pain during trunk surgery. Reducing the number of punctures would avoid complications and would be very useful if analgesia of the entire abdominal wall could be achieved with two punctures. However, prospective studies on the analgesic effects of TAPA block have not been conducted yet.
In this study, we examine the effectiveness of TAPA block in trunk surgery by conducting a randomized controlled trial.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

opioid consumption within 48 hours after surgery

Key secondary outcomes

NRS
side effects


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

TAPA block

Interventions/Control_2

IVPCA

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients undergoing laparoscopic colorectomy and laparoscopic cholecystectomy in the operating room of Juntendo University School of Medicine Shizuoka Hospital

Key exclusion criteria

Patients with bronchial asthma
Patients with reduced renal function (eGFR <30)
Patients who moved to open surgery
Patients with lesions that are not suitable for puncturing the skin at the puncture site
Patients with a history of allergy to local anesthetics
Patients who are considered to be at risk of performing the procedure
Other patients who are judged inappropriate by the investigator

Target sample size

28


Research contact person

Name of lead principal investigator

1st name masateru
Middle name
Last name kumemura

Organization

Juntendo university Shizuoka hospital

Division name

anesthesiology

Zip code

410-2295

Address

1129 Nagaoka, Izunokuni, Shizuoka Prefecture

TEL

055-948-3111

Email

m-kumemura@juntendo.ac.jp


Public contact

Name of contact person

1st name masateru
Middle name
Last name kumemura

Organization

juntendo university shizuoka hospital

Division name

anesthesiology

Zip code

410-2295

Address

1129 Nagaoka, Izunokuni, Shizuoka Prefecture

TEL

055-948-3111

Homepage URL


Email

m-kumemura@juntendo.ac.jp


Sponsor or person

Institute

Nintendo university shizuoka hospital

Institute

Department

Personal name



Funding Source

Organization

Nintendo university shizuoka hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

juntendo university shizuoka hospital

Address

1129 Nagaoka, Izunokuni, Shizuoka Prefecture

Tel

055-948-3111

Email

m-kumemura@juntendoaac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 02 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 01 Month 21 Day

Date of IRB

2020 Year 02 Month 10 Day

Anticipated trial start date

2020 Year 02 Month 11 Day

Last follow-up date

2020 Year 05 Month 30 Day

Date of closure to data entry

2020 Year 05 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 01 Month 31 Day

Last modified on

2020 Year 12 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044855


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name